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Background: Ischemia/reperfusion (IR) is a main cause of acute
kidney injury (AKI). Up-regulated caspase-3, a key enzyme involved in
inflammation and apoptosis, was revealed in renal IR injury and
reversed by a novel cyclic helix B peptide (CHBP), derived from erythro-
poietin. Here, caspase-3 small interfering RNA (C3siRNA) and/or CHBP
were applied in a mouse model to further explore underlying
mechanisms.
Methods: Bilateral renal occlusion for 30 min was performed in male C57BL/
6 mice and followed by 48 h reperfusion. 0.03 mg/kg C3siRNA or its negative
control (NC) was injected intravenously 2 h before ischemia. 24 nmol/kg
CHBP was injected intraperitoneally post reperfusion. Serum and kidney
samples were collected for renal function, histology and molecular biology
analyses.
Results: Serum creatinine and tubulointerstitial damage (TID) score were
increased by IR injury, but decreased by C3siRNA and/or CHBP (all
P < 0.01). In addition, the expression of 17 kD active caspase-3, active cas-
pase-3+ cells and apoptotic cells were raised by IR injury, but reduced by
C3siRNA and/or CHBP (P < 0.01). More interestingly, there was a significant
reduction in TID in the kidneys treated with both C3siRNA and CHBP
compared with its sole treatment.
Conclusion: C3siRNA and CHBP ameliorated IR injury, both of which
might have certain synergetic effects. CHBP might reduce active cas-
pase-3, subsequently affect apoptosis, and improve renal function and
structure.http://dx.doi.org/10.1016/j.hkjn.2015.09.0510025
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Objective: This study was to determine the incidence and mortality rate of
acute kidney injury (AKI) among hospitalized adult patients in a tertiary
metropolitan hospital of China, and to evaluate the impact of AKI on 28-
day mortality, cost and length of stay (LOS).
Methods: Patients of Zhongshan Hospital, Fudan University, Shanghai be-
tween November 3rd, 2014 and November 9th, 2014 were screened by the
hospital medical database. The presence and severity of AKI were assessed
by the KDIGO criteria. Follow-up biochemical and clinical data were used to
determine short-term (28 days) outcomes.
Results: There were 2563 patients during the study period and 92 (3.59%)
met the diagnostic criteria of AKI. The median age of AKI patients was 64
years, 70.7% were male, 12% received renal replacement therapy. 23 pa-
tients (25%) were community-acquired AKI, the leading cause was nephro-
toxic drugs (26.1%), infection (21.7%) and heart failure (17.4%). Hospital-
acquired AKI was 75%, the leading cause was surgery (62.7%), infection
(14.5%) and nephrotoxic drugs (8.7%). The AKI group had significantly
longer LOS than the non AKI group (14 vs. 6 days). The 28d mortality of
AKI was 7.6%. Complete, partial and no renal recovery was observed in
28.3%, 23.9% and 21.7% of the patients, respectively. Of AKI patients,
AKI stage (KDIGO criteria), malignancy and albumin were independent
risk factors of 28-day mortality according to multivariate logistic
regression.
Conclusion: AKI is prevalent in the Chinese hospitalized patients. Slight el-
evations of serum creatinine are associated with significantly increased mor-
tality, LOS and hospital cost. Moreover, outcomes are related directly to the
severity of AKI.http://dx.doi.org/10.1016/j.hkjn.2015.09.0520026
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Background: Emerging evidence indicates that retinoid-related orphan re-
ceptor alpha (RORalpha), a member of the ROR subfamily of nuclear recep-
tors, mediates key cellular adaptions to hypoxia and contributes to
pathophysiology of many disease states. However, the potential renal func-
tions of RORalpha in response to ischemia/reperfusion (I/R) injury remain
unclear. Here, we investigated the renal expression and biological function
of RORalpha in acute kidney injury (AKI).
Methods: I/R injury was induced by 35 min bilateral clamping of the renal
pedicle and 24 h reperfusion in wild-type and staggerer [RORalpha(sg/sg)]
mice, a natural mutant strain lacking RORalpha expression. Renal injury
and RORalpha abundance were analyzed. In addition, human proximal
tubular cell line (HK-2) was used to investigate the expression of RORalpha
under hypoxia.
Results: RORalpha was detected in both mouse renal endothelial and tubular
epithelial cells. Significant up-regulation of RORalpha was found after renal
I/R injury. Compared with wild-type, RORalpha(sg/sg) mice displayed signif-
icantly increased levels of serum creatinine (2.30 0.21 vs. 1.18 0.35 mg/
dl, p < 0.01), renal tissue damage, and pro-inflammatory cytokine produc-
tion after ischemic kidney injury (Figure 1). Further mechanistic studies indi-
cated that RORalpha agonists enhanced transcriptional activity of hypoxia-
inducible factor 1alpha (HIF-1alpha) in HK-2 cells, which was abolished by
siRNA-mediated silencing of endogenous RORalpha.
